To further investigate the role of p53 in the response of colorectal cancer cells to oxaliplatin, we assessed the sensitivity to this agent in a panel of 30 different colorectal cancer cell lines of known p53 mutational status (Mariadason et al, 2003). Here, TP53 is linked to colorectal cancer.